HRP20110054T1 - Derivat triazolona - Google Patents
Derivat triazolona Download PDFInfo
- Publication number
- HRP20110054T1 HRP20110054T1 HR20110054T HRP20110054T HRP20110054T1 HR P20110054 T1 HRP20110054 T1 HR P20110054T1 HR 20110054 T HR20110054 T HR 20110054T HR P20110054 T HRP20110054 T HR P20110054T HR P20110054 T1 HRP20110054 T1 HR P20110054T1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- compound
- triazol
- Prior art date
Links
- FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical class O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 14
- 150000003839 salts Chemical class 0.000 claims abstract 9
- 208000007536 Thrombosis Diseases 0.000 claims abstract 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 238000011321 prophylaxis Methods 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- SWBNRTJFFXVPGP-UHFFFAOYSA-N 4-[5-[(4-carbamimidoylanilino)-(8-methoxy-4h-1,3-benzodioxin-6-yl)methyl]-3-oxo-1h-1,2,4-triazol-2-yl]-1,3-thiazole-5-carboxylic acid Chemical compound C=1C=2COCOC=2C(OC)=CC=1C(C=1NC(=O)N(C2=C(SC=N2)C(O)=O)N=1)NC1=CC=C(C(N)=N)C=C1 SWBNRTJFFXVPGP-UHFFFAOYSA-N 0.000 claims 2
- RTCZPOICLPCXEV-UHFFFAOYSA-N 4-[5-[(4-carbamimidoylanilino)-[2-fluoro-3-(2-hydroxyethoxy)-5-methoxyphenyl]methyl]-3-oxo-1h-1,2,4-triazol-2-yl]-1,3-thiazole-5-carboxylic acid Chemical compound COC1=CC(OCCO)=C(F)C(C(NC=2C=CC(=CC=2)C(N)=N)C=2NC(=O)N(C3=C(SC=N3)C(O)=O)N=2)=C1 RTCZPOICLPCXEV-UHFFFAOYSA-N 0.000 claims 2
- IJDXWECREZKSJZ-UHFFFAOYSA-N 4-[[[2-fluoro-3-(2-hydroxyethoxy)-5-methoxyphenyl]-(3-oxo-2-pyrimidin-2-yl-1h-1,2,4-triazol-5-yl)methyl]amino]benzenecarboximidamide Chemical compound COC1=CC(OCCO)=C(F)C(C(NC=2C=CC(=CC=2)C(N)=N)C=2NC(=O)N(C=3N=CC=CN=3)N=2)=C1 IJDXWECREZKSJZ-UHFFFAOYSA-N 0.000 claims 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims 2
- 206010051055 Deep vein thrombosis Diseases 0.000 claims 2
- 208000010378 Pulmonary Embolism Diseases 0.000 claims 2
- 206010047249 Venous thrombosis Diseases 0.000 claims 2
- 206010008118 cerebral infarction Diseases 0.000 claims 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims 2
- 208000009190 disseminated intravascular coagulation Diseases 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006083486 | 2006-03-24 | ||
| US78668706P | 2006-03-29 | 2006-03-29 | |
| JP2006162594 | 2006-06-12 | ||
| US80487806P | 2006-06-15 | 2006-06-15 | |
| JP2006218819 | 2006-08-10 | ||
| US83841806P | 2006-08-18 | 2006-08-18 | |
| PCT/JP2007/055813 WO2007111212A1 (ja) | 2006-03-24 | 2007-03-22 | トリアゾロン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110054T1 true HRP20110054T1 (hr) | 2011-02-28 |
Family
ID=38950011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110054T HRP20110054T1 (hr) | 2006-03-24 | 2011-01-24 | Derivat triazolona |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US7816522B2 (zh) |
| EP (2) | EP2000465B1 (zh) |
| JP (1) | JP5016592B2 (zh) |
| KR (1) | KR101362024B1 (zh) |
| AT (2) | ATE557010T1 (zh) |
| AU (1) | AU2007230346B2 (zh) |
| BR (1) | BRPI0709101A2 (zh) |
| CA (1) | CA2647423C (zh) |
| CY (1) | CY1111271T1 (zh) |
| DE (1) | DE602007011231D1 (zh) |
| DK (1) | DK2000465T3 (zh) |
| HK (1) | HK1123808A1 (zh) |
| HR (1) | HRP20110054T1 (zh) |
| IL (1) | IL194188A (zh) |
| MX (1) | MX2008012031A (zh) |
| MY (1) | MY146537A (zh) |
| NO (1) | NO20084441L (zh) |
| NZ (1) | NZ571441A (zh) |
| PL (1) | PL2000465T3 (zh) |
| PT (1) | PT2000465E (zh) |
| RS (1) | RS52030B (zh) |
| SA (1) | SA07280131B1 (zh) |
| SI (1) | SI2000465T1 (zh) |
| TW (1) | TWI389894B (zh) |
| WO (1) | WO2007111212A1 (zh) |
| ZA (1) | ZA200805758B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1810965A4 (en) * | 2004-10-13 | 2009-10-28 | Eisai R&D Man Co Ltd | HYDRAZIDE DERIVATIVES |
| ATE557010T1 (de) * | 2006-03-24 | 2012-05-15 | Eisai R&D Man Co Ltd | Triazolonderivat |
| US7807690B2 (en) | 2007-09-21 | 2010-10-05 | Eisai R&D Management Co., Ltd. | 2,3-dihydro-iminoisoindole derivatives |
| KR20100089091A (ko) * | 2007-10-26 | 2010-08-11 | 아스트라제네카 아베 | Ｍｇｌｕｒ5의 조절제로서의 아미노 1,2,4-트리아졸 유도체 |
| TW200924774A (en) * | 2007-10-26 | 2009-06-16 | Astrazeneca Ab | Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mGluR5 |
| TW201206905A (en) | 2010-05-20 | 2012-02-16 | Eisai R & Amp D Man Co Ltd | Prodrug of triazolone compound |
| WO2013134562A1 (en) * | 2012-03-09 | 2013-09-12 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| CN102993109A (zh) * | 2012-12-03 | 2013-03-27 | 浙江工业大学 | 一种脒化合物的制备方法 |
| WO2014099503A1 (en) | 2012-12-20 | 2014-06-26 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| CN105579440A (zh) | 2013-09-06 | 2016-05-11 | 因森普深2公司 | 三唑酮化合物及其应用 |
| EP3588064B1 (en) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Oh radical detection probe, oh radical measurement device, and oh radical measurement method |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2005000A (en) * | 1931-07-18 | 1935-06-18 | L N Miller Engineering Corp | Differential motor |
| EP0019586A1 (de) | 1979-05-11 | 1980-11-26 | Ciba-Geigy Ag | Neue antithrombotische Kombinationspräparate |
| SU1512055A1 (ru) | 1987-12-04 | 1992-07-23 | Пермский фармацевтический институт | Дигидрохлорид гидразида N-ацетил-N-аллилантраниловой кислоты, про вл ющий антиагрегатную активность по отношению к тромбоцитам плазмы крови |
| AU8747598A (en) | 1997-08-27 | 1999-03-16 | Kissei Pharmaceutical Co. Ltd. | 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| KR20010082515A (ko) | 1998-02-17 | 2001-08-30 | 우에노 도시오 | 아미디노 유도체 및 그 유도체를 유효 성분으로서함유하는 약제 |
| CA2321538A1 (en) | 1998-03-27 | 1999-10-07 | Dupont Pharmaceuticals Company | Disubstituted pyrazolines and triazolines as factor xa inhibitors |
| DE69919743T2 (de) | 1998-12-14 | 2005-09-01 | F. Hoffmann-La Roche Ag | Phenylglycin-derivate |
| CN100488947C (zh) | 1999-01-13 | 2009-05-20 | 杰南技术公司 | 丝氨酸蛋白酶抑制剂 |
| FR2791683A1 (fr) | 1999-03-30 | 2000-10-06 | Synthelabo | Derives de n-sulfonyl-dipeptides, leur preparation et leur application en therapeutique |
| FR2793247B1 (fr) | 1999-05-04 | 2001-06-22 | Synthelabo | Derives de 6-[[(aryl et heteroaryl)oxy]methyl]naphtalene-2- carboximidamide, leur preparation et leur application en therapeutique |
| US6548694B2 (en) | 2000-05-23 | 2003-04-15 | Hoffman-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| EP1162194A1 (en) | 2000-06-06 | 2001-12-12 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| IL158491A0 (en) | 2001-04-19 | 2004-05-12 | Eisai Co Ltd | 2-iminopyrrolidine derivatives |
| EP1312602A1 (en) | 2001-11-15 | 2003-05-21 | Eisai Co., Ltd. | Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them |
| JP4209659B2 (ja) | 2001-11-15 | 2009-01-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アミジノ誘導体並びにそれを用いた抗血液凝固剤および血栓症治療剤 |
| AU2003284001A1 (en) * | 2002-10-07 | 2004-05-04 | Bristol-Myers Squibb Company | Triazolone and triazolethione derivatives |
| EP1479679A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Triazole-derivatives as factor Xa inhibitors |
| EP1810965A4 (en) | 2004-10-13 | 2009-10-28 | Eisai R&D Man Co Ltd | HYDRAZIDE DERIVATIVES |
| DE602005009252D1 (de) | 2004-12-08 | 2008-10-02 | Bristol Myers Squibb Co | Heterocyclische verbindungen als inhibitoren von faktor viia |
| ATE557010T1 (de) | 2006-03-24 | 2012-05-15 | Eisai R&D Man Co Ltd | Triazolonderivat |
| US7807690B2 (en) | 2007-09-21 | 2010-10-05 | Eisai R&D Management Co., Ltd. | 2,3-dihydro-iminoisoindole derivatives |
-
2007
- 2007-03-22 AT AT10157326T patent/ATE557010T1/de active
- 2007-03-22 EP EP07739256A patent/EP2000465B1/en active Active
- 2007-03-22 MX MX2008012031A patent/MX2008012031A/es active IP Right Grant
- 2007-03-22 PL PL07739256T patent/PL2000465T3/pl unknown
- 2007-03-22 MY MYPI20083555A patent/MY146537A/en unknown
- 2007-03-22 AU AU2007230346A patent/AU2007230346B2/en not_active Ceased
- 2007-03-22 NZ NZ571441A patent/NZ571441A/en not_active IP Right Cessation
- 2007-03-22 CA CA2647423A patent/CA2647423C/en not_active Expired - Fee Related
- 2007-03-22 RS RS20110118A patent/RS52030B/en unknown
- 2007-03-22 US US11/723,893 patent/US7816522B2/en not_active Expired - Fee Related
- 2007-03-22 DE DE602007011231T patent/DE602007011231D1/de active Active
- 2007-03-22 SI SI200730515T patent/SI2000465T1/sl unknown
- 2007-03-22 PT PT07739256T patent/PT2000465E/pt unknown
- 2007-03-22 WO PCT/JP2007/055813 patent/WO2007111212A1/ja active Application Filing
- 2007-03-22 AT AT07739256T patent/ATE491694T1/de active
- 2007-03-22 KR KR1020087025698A patent/KR101362024B1/ko not_active IP Right Cessation
- 2007-03-22 EP EP10157326A patent/EP2194046B1/en active Active
- 2007-03-22 BR BRPI0709101-0A patent/BRPI0709101A2/pt not_active IP Right Cessation
- 2007-03-22 DK DK07739256.1T patent/DK2000465T3/da active
- 2007-03-22 JP JP2008507453A patent/JP5016592B2/ja not_active Expired - Fee Related
- 2007-03-23 TW TW096110040A patent/TWI389894B/zh not_active IP Right Cessation
- 2007-03-24 SA SA7280131A patent/SA07280131B1/ar unknown
-
2008
- 2008-07-01 ZA ZA2008/05758A patent/ZA200805758B/en unknown
- 2008-09-17 IL IL194188A patent/IL194188A/en not_active IP Right Cessation
- 2008-10-22 NO NO20084441A patent/NO20084441L/no not_active Application Discontinuation
-
2009
- 2009-04-21 HK HK09103660.4A patent/HK1123808A1/xx not_active IP Right Cessation
-
2010
- 2010-03-29 US US12/748,806 patent/US7928228B2/en not_active Expired - Fee Related
-
2011
- 2011-01-13 US US13/006,004 patent/US8163787B2/en not_active Expired - Fee Related
- 2011-01-24 HR HR20110054T patent/HRP20110054T1/hr unknown
- 2011-02-28 CY CY20111100231T patent/CY1111271T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110054T1 (hr) | Derivat triazolona | |
| US11198673B2 (en) | Therapeutic compounds and compositions | |
| US7767665B2 (en) | 1,3-benzothiazinone derivatives and use thereof | |
| US6586453B2 (en) | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 | |
| AU2015231234B2 (en) | Antifungal compound process | |
| RU2019120990A (ru) | Бициклические гетероарильные производные в качестве стимуляторов cftr | |
| JP2014532070A5 (zh) | ||
| CN103119031B (zh) | 取代酰胺化合物 | |
| JP2013121919A (ja) | 血漿カリクレイン阻害剤 | |
| JP2010513304A5 (zh) | ||
| JP2004517894A5 (zh) | ||
| RU2014124101A (ru) | Использование тиено- и фуро- пиримидинов и пиримидинов в качестве ингибиторов калиевых каналов | |
| JP2008543972A5 (zh) | ||
| JP2015164972A5 (zh) | ||
| JP2004517069A5 (zh) | ||
| JP2020526547A5 (zh) | ||
| US20180250280A1 (en) | Substituted oxopyridine derivatives | |
| JP2005528459A5 (zh) | ||
| JP2008519826A5 (zh) | ||
| AU2002247726C1 (en) | 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry | |
| JP2018522024A5 (zh) | ||
| JP2008521844A (ja) | 環状イミノカルバメート類およびそれらの使用 | |
| EP3805210B1 (en) | Novel compound and pharmaceutical composition comprising same | |
| US20170326125A1 (en) | Multisubstituted aromatic compounds as inhibitors of thrombin | |
| RU2007128065A (ru) | Новые гетероарилацетамиды |